Baird Medical Investment Holdings (BDMD) Raw Materials (2023 - 2025)

Baird Medical Investment Holdings' Raw Materials history runs 3 years deep, the most recent figure standing at $374738.0 for Q4 2025.

• In Q4 2025, Raw Materials rose 7.4% year-over-year to $374738.0; the TTM figure through Dec 2025 stood at $374738.0 (up 7.4% YoY), while the FY2025 annual figure was $374738.0, up 7.4% from the prior year.
• Raw Materials was $374738.0 for Q4 2025 at Baird Medical Investment Holdings, up from $348910.0 in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $516346.0 in Q4 2023 to a low of $348910.0 in Q4 2024.
• Historically, Raw Materials has averaged $413331.3 across 3 years, with a median of $374738.0 in 2025.
• The sharpest annual moves came in 2024 and 2025: Raw Materials sank 32.43% in 2024, then increased 7.4% in 2025.
• A 3-year view of Raw Materials shows it stood at $516346.0 in 2023, then sank by 32.43% to $348910.0 in 2024, then advanced by 7.4% to $374738.0 in 2025.
• The last three Raw Materials figures came in at $374738.0 (Q4 2025), $348910.0 (Q4 2024), and $516346.0 (Q4 2023), per Business Quant data.